Literature DB >> 19513795

Preemptive surgery for premalignant foregut lesions.

Rohit R Sharma1, Mark J London, Laura L Magenta, Mitchell C Posner, Kevin K Roggin.   

Abstract

INTRODUCTION: Preemptive surgery is the prophylactic removal of an organ at high risk for malignant transformation or the resection of a precancerous or "early" malignant neoplasm in an individual with a hereditary predisposition to cancer. Recent advances in molecular diagnostic techniques have improved our understanding of the biologic behavior of these conditions. Predictive testing is an emerging field that attempts to assess the potential risk of cancer development in predisposed individuals. Despite substantial improvement in these forms of testing, all results are imperfect. This information often becomes an important tool that is used by healthcare providers to evaluate the risk-benefit ratio of various risk modifying strategies (i.e., intensive surveillance or preemptive surgery).
METHODS: A systematic literature review was performed using Medline and the bibliographies of all referenced publications to identify articles relating to preemptive surgery for premalignant foregut lesions. RESULTS AND DISCUSSION: In this review, we outline the controversies surrounding predictive risk assessment, surveillance strategies, and preemptive surgery in the management of high-grade dysplasia (HGD) in Barrett's esophagus (BE), hereditary diffuse gastric cancer (HDGC), bile duct cysts, primary sclerosing cholangitis (PSC), and pancreatic cystic neoplasms. Resection of BE is supported by the progressive nature of the disease, the risk of occult carcinoma, and the lethality of esophageal cancer. Prophylactic total gastrectomy for HDGC appears reasonable in the absence of accurate screening tests but must be balanced by the impact of surgical complications and altered quality of life. Surgical resection of biliary cysts theoretically eliminates the exposed epithelium to decrease the lifetime risk of cholangiocarcinoma. Liver transplantation for PSC remains controversial given the scarcity of donor organs and inability to accurately identify high-risk individuals. Given the uncertain natural history of pancreatic cystic neoplasms, the merits of selective versus obligatory resection will continue to be debated.
CONCLUSIONS: Preemptive operations require optimal judgment and surgical precision to maximize function and enhance survival. Ultimately, balancing the risk of surgical intervention with less invasive interventions or observation must be individualized on a case-by-case basis.

Entities:  

Mesh:

Year:  2009        PMID: 19513795     DOI: 10.1007/s11605-009-0935-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  161 in total

1.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

Review 2.  Primary sclerosing cholangitis: epidemiology, natural history, and prognosis.

Authors:  Cynthia Levy; Keith D Lindor
Journal:  Semin Liver Dis       Date:  2006-02       Impact factor: 6.115

3.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.

Authors:  Vijay Sujendran; Giuseppe Sica; Bryan Warren; Nicholas Maynard
Journal:  Eur J Cardiothorac Surg       Date:  2005-09-26       Impact factor: 4.191

5.  Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis.

Authors:  J B Hulscher; J G Tijssen; H Obertop; J J van Lanschot
Journal:  Ann Thorac Surg       Date:  2001-07       Impact factor: 4.330

Review 6.  Etiology and natural history of primary sclerosing cholangitis.

Authors:  K V Narayanan Menon; R H Wiesner
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

Review 7.  Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia.

Authors:  Richard F Heitmiller
Journal:  Langenbecks Arch Surg       Date:  2003-02-20       Impact factor: 3.445

8.  Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.

Authors:  R G Lee
Journal:  Am J Surg Pathol       Date:  1985-12       Impact factor: 6.394

9.  Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view.

Authors:  Renato Romagnoli; Jean-Marie Collard; Christian Gutschow; Nadine Yamusah; Mauro Salizzoni
Journal:  J Am Coll Surg       Date:  2003-09       Impact factor: 6.113

10.  High-grade dysplasia in the columnar-lined esophagus.

Authors:  N K Altorki; M Sunagawa; A G Little; D B Skinner
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

View more
  3 in total

Review 1.  Early detection and prevention of pancreatic cancer: is it really possible today?

Authors:  Marco Del Chiaro; Ralf Segersvärd; Matthias Lohr; Caroline Verbeke
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 2.  Cancer surveillance in patients with primary sclerosing cholangitis.

Authors:  Nataliya Razumilava; Gregory J Gores; Keith D Lindor
Journal:  Hepatology       Date:  2011-11       Impact factor: 17.425

Review 3.  New and old technologies for organ replacement.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2013-04       Impact factor: 2.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.